We are live on ! Find out more
ECM

Endurant Capital Management Portfolio holdings

AUM $17.4M
1-Year Est. Return 7.38%
This Fund
S&P 500
This Quarter Est. Return
+11.35%
1 Year Est. Return
+7.38%
3 Year Est. Return
+18.38%
5 Year Est. Return
+100.61%
10 Year Est. Return
–
AUM
$303M
AUM Growth
+$47.8M
Cap. Flow
+$22.2M
Cap. Flow %
7.34%
Top 10 Hldgs %
34.65%
Holding
115
New
28
Increased
31
Reduced
37
Closed
19

Top Buys

Rank Stock Value
1
GMED icon
Globus Medical
GMED
+$9.42M
2
ESRX
Express Scripts Holding Company
ESRX
+$5.8M
3
ENTA icon
Enanta Pharmaceuticals
ENTA
+$5.1M
4
STJ
St Jude Medical
STJ
+$4.11M
5
BAX icon
Baxter International
BAX
+$4.05M

Top Sells

Rank Stock Value
1
EHC icon
Encompass Health
EHC
+$7.11M
2
UHS icon
Universal Health Services
UHS
+$5.84M
3
DGX icon
Quest Diagnostics
DGX
+$5.57M
4
CYH icon
Community Health Systems
CYH
+$4.33M
5
ELV icon
Elevance Health
ELV
+$4.22M

Sector Composition

Rank Sector Weight
1 Healthcare 87.89%
2 Financials 0.91%
3 Technology 0.66%
4 Consumer Staples 0.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NUVA
51
DELISTED
NuVasive, Inc.
NUVA
$2.14M 0.71%
+46,600
New +$2.16M
CSLT
52
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$2.01M 0.66%
+259,300
New +$2.22M
OCR
53
DELISTED
OMNICARE INC
OCR
$2M 0.66%
25,945
-7,100
-21% -$539K
JAZZ icon
54
Jazz Pharmaceuticals
JAZZ
$15.8B
$1.85M 0.61%
+10,700
New +$1.84M
CI icon
55
Cigna
CI
$74.5B
$1.76M 0.58%
13,600
-4,800
-26% -$558K
KND
56
DELISTED
Kindred Healthcare
KND
$1.72M 0.57%
72,400
+13,700
+23% +$278K
VRTX icon
57
Vertex Pharmaceuticals
VRTX
$119B
$1.7M 0.56%
14,400
+3,600
+33% +$431K
XENT
58
DELISTED
Intersect ENT, Inc
XENT
$1.63M 0.54%
+63,000
New +$1.44M
CLDX icon
59
Celldex Therapeutics
CLDX
$2.96B
$1.56M 0.52%
+3,733
New +$1.34M
PARN
60
DELISTED
Parnell Pharmaceuticals Holdings Ltd
PARN
$1.41M 0.47%
287,163
+37,736
+15% +$174K
JNJ icon
61
Johnson & Johnson
JNJ
$613B
$1.39M 0.46%
13,800
+8,500
+160% +$864K
EVHC
62
DELISTED
Envision Healthcare Holdings Inc
EVHC
$1.37M 0.45%
11,927
-27,455
-70% -$2.99M
SPNC
63
DELISTED
Spectranetics Corp
SPNC
$1.29M 0.43%
37,150
+22,200
+148% +$755K
ILMN icon
64
Illumina
ILMN
$30B
$1.23M 0.41%
6,830
-822
-11% -$155K
ELOS
65
DELISTED
Syneron Medical Ltd
ELOS
$1.22M 0.4%
+98,800
New +$1.09M
NXTM
66
DELISTED
NxStage Medical Inc.
NXTM
$1.16M 0.38%
+67,093
New +$1.19M
COR icon
67
Cencora
COR
$60B
$1.15M 0.38%
10,100
-200
-2% -$20.1K
SRNE
68
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$1.13M 0.37%
97,940
-50,313
-34% -$582K
EGRX
69
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$1.07M 0.35%
+25,500
New +$723K
SSRG
70
DELISTED
SYMMETRY SURGICAL INC COMMON STK
SSRG
$997K 0.33%
136,052
-7,800
-5% -$58.9K
ABT icon
71
Abbott
ABT
$185B
$957K 0.32%
20,650
-3,100
-13% -$142K
BLUE
72
DELISTED
bluebird bio
BLUE
$942K 0.31%
+602
New +$794K
RAD
73
DELISTED
Rite Aid Corporation
RAD
$919K 0.3%
5,285
-5,440
-51% -$847K
XRAY icon
74
Dentsply Sirona
XRAY
$2.83B
$906K 0.3%
+17,800
New +$918K
ANAC
75
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$821K 0.27%
14,200
-11,800
-45% -$501K
1 2
3
4 5

Similar funds

VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
SCM
Somerset Capital Management London, United Kingdom $8.12M AUM 21.3% 1-Year Est. Return
FWM
Fiat Wealth Management Wayzata, Minnesota $7.9M AUM
TOPU
Trustees of Princeton University Princeton, New Jersey $7.77M AUM
CCMU
Cheyne Capital Management (UK) London, United Kingdom $27.9M AUM 36.14% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
HSCU
Half Sky Capital (UK) London, United Kingdom $30.5M AUM 67.32% 1-Year Est. Return

Endurant Capital Management's Q1 2015 Portfolio in Review

As of Q1 2015, Endurant Capital Management held 115 positions worth $303M, up 19% from $255M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Endurant Capital Management deployed $22.2M of net new capital in Q1 2015, opening 28 new positions and adding to 31 existing holdings. Its largest new stake was Express Scripts Holding Company: 69,200 shares worth $6M.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets, up from 86% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Encompass Health, an estimated $7.11M trimmed.

  • Endurant Capital Management's largest Q1 2015 buy was Express Scripts Holding Company: 69,200 shares worth $6M.
  • Endurant Capital Management added most to Globus Medical in Q1 2015, an estimated $9.42M increase.
  • Endurant Capital Management's biggest Q1 2015 reduction was Encompass Health, cutting an estimated $7.11M.
  • Endurant Capital Management fully exited Quest Diagnostics in Q1 2015, selling an estimated $5.57M.
  • Endurant Capital Management's ten largest holdings make up 35% of its $303M portfolio in Q1 2015.
  • Endurant Capital Management opened 28 new positions and closed 19 in Q1 2015.
  • Endurant Capital Management's portfolio value rose 19% quarter-over-quarter to $303M.

Based on Endurant Capital Management's 13F filing for Q1 2015, filed 15 May 2015.